Sixty polyoxometalates were examined for anti-influenza A virus (FluV-A) activity in vitro. Two of the most potent and least cytotoxic compounds, PM-504 K9H5(Ge2Ti6W18O77)16H2O] and PM-523 (iPrNH3)6H [PTi2W10O38(O2)9H2O2] were selected for further studies. Examination of the antiviral effects of PM-504 and PM-523 against other human ortho- and paramyxoviruses revealed that both compounds had broad spectrum antimyxovirus activities. From a time of addition study and FACS analysis for influenza A virus infected cells, the compounds were found not to inhibit binding of virus to MDCK cells. However, these compounds inhibited haemolysis of chicken erythrocytes by virus and also inhibited fluorescence dequenching of octadecylrhodamine B-labelled virus after binding to cells. This indicates that these polyoxometalates inhibited fusion of the virus envelope to the cellular membrane.
BabaM.PauwelsR.BalzariniJ.ArnoutJ.DesmyterJ., and De ClercqE. (1988a) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA85: 6132–6136.
2.
BabaM.SnoeckR.PauwelsR, and De ClercqE. (1988b) Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother32: 1742–1745.
3.
HillC.L.WeeksM.S., and SchinaziR.F. (1990) Anti-HIV activitiy, toxicity, and stability studies of representative structural families of polyoxometalates. J Med Chem33: 2767–2772.
4.
HoekstraD.de BoerT.KlappeK., and WilschutJ. (1984) Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry23: 5675–5681.
5.
HosoyaMBalzariniJ.ShigetaS., and De ClercqE. (1991) Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the taraget amino acid sequences of the viral envelope glycoproteins. Antimicrob Agents Chemother35: 2515–2520.
6.
HuangR.T.C.RottR., and KelnkH.-D. (1981) In fluenza viruses cause hemolysis and fusion of cells. Virology110: 243–247.
7.
IkedaS.NeytsJ.YamamotoN.MurrerB.TeobaldB.BossardG.HensonG.AbramsM.PickerD., and De ClercqE. (1993a) In vitro activities of a novel series of polyoxosilicotungstates against human myxo-, herpes- and retroviruses. Antiviral Chem Chemother4: 253–262.
8.
IkedaS.NishiyaS.YamamotoA.YamaseT.NishimuraC., and De ClercqE. (1993b) Activity of a Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice. Role of potential macrophage activation. J Med Virol41: 191–195.
9.
LowyR.J.SarkerD.P.ChenY., and BlumenthalR. (1990) Observation of single influenza virus-cell fusion and measurement by fluorescence video microscopy. Proc Natl Acad Sci USA87: 1850–1854.
10.
Lusher-MattiM., and GluckR. (1990) Dextran sulfate inhibits the fusion of influenza virus with model membrane, and supresses influenzavirus replication in vivo. Antiviral Res14: 39–50.
11.
MitsuyaH.D.LooneyJ.KunoS.UenoR.Wong-StaalF., and BroderS. (1988) Dextran sulfate suppression of viruses in the HIV family; inhibition of virion binding to CD4 + cells. Science240: 646–649.
12.
MoriS.WatanabeW., and ShigetaS. (1995) A colorimetric LDH assay for the titration of infectivity and evaluation of anti-viral activity against ortho- and paramyxoviruses. Tohoku J Exp Med177: 315–325.
13.
MorrisS.J.SarkerD.P.WhiteJ.M., and BlumenthalR. (1989) Kinetics of pH dependent fusion between 3T3 fibroblasts expressing hemagglutinin and red blood cells. J Biol Chem264: 3972–3978.
14.
NicholsE.MockD.J., and RobertsN.J.Jr. (1992) Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytesmacrophages and lymphocytes. Arch Virol130: 441–445.
15.
PauwelsR.BalzariniJ.BabaM.SnoeckR.ScholsD.HerdewijnP.DesmyterJ., and De ClercqE. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Meth20: 309–321.
16.
ShigetaS.MoriS.WatanabeJ.BabaM.KhenkinA.M.HillC.L., and SchinaziR.F. (1995) In vitro antimyxovirus and anti-human immunodeficiency virus activities of polyoxometalates. Antiviral Chem Chemother6: 114–122.
17.
Wunderi-AllenspachH., and OttS. (1990) Kinetics of fusion and lipid transfer between virus receptor containing liposomes and influenza viruses as measured with the octadecylrhodamine B chloride assay. Biochemistry29: 1990–1997.
18.
YamamotoN.ScholsD.De ClercqE.DebyserZ.PauwelsR.BalzariniJ.NakashimaH.BabaM.HosoyaM.SnoecR.NeytsJ.AndreiG.MurrerB.A.TheobaldB.BossardG.HensonG.AbramsM., and PickerD. (1992) Mechanism of antihuman immunodeficiency virus action of polyoxometalates, a class of broad spectrum antiviral agents. Mol Pharmacol42: 1109–1117.
19.
YamaseT.OzekiT., and MotomuraS. (1992) 183WNMR and x-ray crystallographic studies on the peroxo complexes of the Ti substrated α-Keggin typed tungstophosphates. Bull Chem Soc Jpn65: 1453–1459.
20.
YamaseT.OzekiT.SakamotoH.NishiyaS., and YamamotoA. (1993) Structure of hexatitano octadecatungstodigermanate. Bull Chem Soc Jpn66: 103–108.
